摘要
目的探讨乳腺钼靶引导下三维立体定位精准治疗乳腺触诊阴性病变(NPBL)的临床应用价值。方法回顾性分析我院收治的184例行乳腺钼靶引导下三维立体定位精准治疗的NPBL患者穿刺定位、手术切除及病理结果。结果 184例NPBL患者中,182例(98.91%)穿刺成功,2例穿刺失败。182例穿刺成功者中,乳腺癌占17.58%(32/182),其中浸润性导管癌8例,导管内癌24例;不典型增生占1.10%(2/182);良性病变占81.32%(148/182),其中导管内乳头状瘤12例,乳腺纤维腺瘤50例,分叶状肿瘤1例,乳腺病85例。良性病变及不典型增生患者均行乳房病变切除术;32例乳腺癌患者中,2例行乳房肿瘤切除术,8例行乳房单纯切除术,22例行乳腺癌改良根治术。切除后再次摄片显示病变完全切除。结论乳腺钼靶引导下三维立体定位精准切除NPBL安全、可靠,有助于提高早期乳腺癌检出率,改善预后,适合基层医院推广。
Objective To explore the clinical application value of mammography-guided three-dimensional localization in precise treatment of patients with non-palpable breast lesions （NPBL）. Methods The data of puncture location, surgical excision, and pathological findings of 184 patients with NPBL who admitted in our hospital from June 2010 to June 2017 and underwent mammography-guided three-dimensional localization of precise treatment was analyzed retrospectively. Results Among 184 patients with NPBL, 182 cases for the punc-ture were successful （98.91%） and 2 cases were failure. In the 182 successful puncture patients, patients with breast cancer accounted for 17.58% （32/182）, including 8 invasive ductal carcinoma patients and 24 intraductal carcinoma patients. Patients with atypical hyperplasia accounted for 1.10% （2/182）, patients with benign lesions accounted for 81.32% （148/182）, including 12 intraductal papillomas patients, 50 breast fibroadenomas patients, 1 phyllodes tumor patient and 85 breast diseases patients. Patients with benign lesions （148 cases） and atypi-cal hyperplasia （2 cases） were treated with resection of breast lesions. Among the 32 patients with breast cancer, 2 patients were treated with resection of breast tumors, 8 patients were treated with simple mastectomy, and 22 patients were treated with modified radical mastectomy. After the resection, the radiography showed that the lesions of patients were completely removed. Conclusion Mammography guided three-dimensional localization of precise resection for treatment of NPBL patients is safe and reliable. It helps to improve the detection rate of early breast cancer. It is suitable for promotion in hospitals.
出处
《肿瘤药学》
CAS
2018年第1期98-100,107,共4页
Anti-Tumor Pharmacy
基金
2015年常熟市卫生局重点资助项目(csws201506)
关键词
乳腺钼靶
导丝定位
乳腺触诊阴性病变
精准治疗
Mammography
Wire guided localization
Non-palpable breast lesion
Precise treatment
作者简介
吴旦平,男,主任医师,研究方向：甲乳外科、甲状腺乳腺疾病的诊治,E-mail：wudanping1976@163.com.
